Related Experiment Video
Updated: Feb 10, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Gamma synuclein is a novel Twist1 target that promotes TGF-β-induced cancer cell migration and invasion
Ting Shao1, Peiying Song1, Hui Hua2
1State Key Laboratory of Biotherapy, Section of Oncogene, Cancer Center, West China Hospital, Sichuan University and Collaboratory Inovation Center for Biotherapy, Chengdu, China.
Abstract:
Transforming growth factor β (TGF-β) is critical for embryonic development, adult tissue homeostasis, and tumor progression. TGF-β suppresses tumors at early stage, but promotes metastasis at later stage through oncogenes such as Twist1. Gamma-synuclein (SNCG) is overexpressed in a variety of invasive and metastatic cancer. Here, we show that TGF-β induces SNCG expression by Smad-Twist1 axis, thus promoting TGF-β- and Twist1-induced cancer cell migration and invasion. We identify multiple Twist1-binding sites (E-boxes) in SNCG promoter. Chromatin immunoprecipitation and luciferase assays confirm the binding of Twist1 to the E-boxes of SNCG promoter sequence (-129/-1026 bp). Importantly, the Twist1-binding site close to the transcription initiation site is critical for the upregulation of SNCG expression by TGF-β and Twist1. Mutations of Twist1 motif on the SNCG promoter constructs markedly reduces the promoter activity. We further show that TGF-β induces Twist1 expression through Smad thereby enhancing the binding of Twist1 to SNCG promoter, upregulating SNCG promoter activity and increasing SNCG expression. SNCG knockdown abrogates TGF-β- or Twist1-induced cancer cell migration and invasion. Finally, SNCG knockdown inhibits the promotion of cancer metastasis by Twist1. Together, our data demonstrate that SNCG is a novel target of TGF-β-Smad-Twist1 axis and a mediator of Twist1-induced cancer metastasis.
Insights
Transforming growth factor beta (TGF-β) signaling promotes cancer metastasis by inducing gamma-synuclein (SNCG) via the Smad-Twist1 pathway. SNCG acts as a key mediator, driving cancer cell migration and invasion.
Area of Science:
- Molecular Biology
- Oncology
- Cell Biology
Background:
- Transforming growth factor beta (TGF-β) plays a dual role in cancer, suppressing early tumors but promoting metastasis later.
- Oncogenes like Twist1 are implicated in TGF-β-driven metastasis.
- Gamma-synuclein (SNCG) is frequently overexpressed in invasive and metastatic cancers.
Purpose of the Study:
- To elucidate the mechanism by which TGF-β and Twist1 regulate SNCG expression.
- To investigate the role of SNCG as a mediator in TGF-β- and Twist1-induced cancer cell migration and invasion.
Main Methods:
- Identification of Twist1-binding sites (E-boxes) in the SNCG promoter.
- Chromatin immunoprecipitation and luciferase assays to confirm Twist1 binding and promoter activity.
- SNCG knockdown experiments to assess its role in cell migration, invasion, and metastasis.
Main Results:
- TGF-β induces SNCG expression through the Smad-Twist1 axis.
- Twist1 directly binds to E-boxes in the SNCG promoter, enhancing its activity.
- SNCG knockdown abrogates TGF-β- or Twist1-induced cancer cell migration, invasion, and metastasis.
Conclusions:
- SNCG is a novel target of the TGF-β-Smad-Twist1 signaling pathway.
- SNCG acts as a critical mediator of Twist1-induced cancer cell migration, invasion, and metastasis.
Related Concept Videos
TGF - β Signaling Pathway
Cancer Cell Migration through Invadopodia
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cell Migration
Cell Migration
The Eukaryotic Promoter Region

